Jun 23, 2009 - Santarus, Inc., a specialty biopharmaceutical company, today announced that Schering-Plough HealthCare Products, Inc. has received notification from the U.S. Food and Drug Administration (FDA) of a December 2009 action date for an over-the-counter (OTC) ZEGERID® branded omeprazole/sodium bicarbonate product with the dosage strength of 20 mg of omeprazole.
The details can be read here.
No comments:
Post a Comment